Sanjay Varma
Psychiatry · Princeton, NJNPI 1760593487
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,111 of the $8,196 with a category attached, or 86.8%. It is spread thinly across 31 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,602 and has fallen 57.3% since, to $1,110 in 2025. Among psychiatry clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 420 payments — averaging $19.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Lundbeck LLC$720
- AbbVie$617
- Axsome Therapeutics, Inc.$545
- Sunovion Pharmaceuticals Inc.$432
- plus $3K from 25 others
Across 31 payments — averaging $15,202 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- H. Lundbeck A S$231K
- E.r. Squibb & Sons, L.L.C.$170K
- Boehringer Ingelheim$47K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$13K
- Boehringer Ingelheim Pharma GmbH & Co.kg$9K
- AbbVie$532
What the payments were for
- Travel & lodging$1,08513%
- Food & beverage$7,11187%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 15 | $1,504 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 69 | $1,342 |
| Lundbeck LLC | 44 | $720 |
| AbbVie(2 entities) | 47 | $617 |
| Axsome Therapeutics, Inc. | 26 | $545 |
| Sunovion Pharmaceuticals Inc. | 26 | $432 |
| Tris Pharma Inc | 24 | $358 |
| Vanda Pharmaceuticals Inc. | 23 | $332 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $322 |
| Otsuka America Pharmaceutical, Inc. | 22 | $319 |
| Lilly USA, LLC | 10 | $290 |
| Corium, LLC | 20 | $284 |
| Johnson & Johnson | 16 | $260 |
| Teva Pharmaceuticals USA, Inc. | 17 | $253 |
| Neurocrine Biosciences, Inc. | 7 | $110 |
| Ironshore Pharmaceuticals Inc. | 6 | $83 |
| Idorsia Pharmaceuticals US Inc | 5 | $72 |
| Collegium Pharmaceutical, Inc. | 3 | $49 |
| Harmony Biosciences LLC | 2 | $39 |
| Genentech USA, Inc. | 1 | $38 |
| Indivior Inc. | 3 | $38 |
| Biogen | 2 | $33 |
| Alkermes, Inc. | 2 | $30 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Neos Therapeutics, LP | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| OWP Pharmaceuticals, Inc. | 1 | $13 |
| Noven Therapeutics, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$124
How this compares
$8,196 in reported general payments places this provider in the 90th percentile of 1,119 psychiatry providers in New Jersey.
Other psychiatry in Princeton
- Jeffrey ApterPrinceton$12K
- Marc CantillonLivingston$522K
- Robert BransfieldRed Bank$415K
- Erika ConcepcionLong Branch$354K
- Leon RosenbergCherry Hill$257K
- Lloyd AlceraMarlton$187K
- Gary SmallHackensack$170K
- Shankar SrinivasanParsippany$155K
- Matthew PiteraToms River$153K
- Boris BorodulinEast Brunswick$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.